Due to this fact, dual antiplatelet therapy is often employed, comprising using of aspirin in combination with ADP receptor (P2Y12) blockers in heart attacks and following the placement of a coronary artery stent (Yusuf et al., 2001; Steinhubl et al., 2002). The gene discussed is P2RY1; the disease is myocardial infarction.